ADI
57
-2
URBN
58
6
CTSH
42
-3
PG
33
-2
FOX
60
-2
CMA
50
-9
PNW
49
-4
AAP
45
-2
EL
45
-7
MUR
44
-5
MAR
51
-8
GLW
45
-3
GT
46
-3
PFE
23
-6
DRI
43
-2
RF
54
-9
CF
59
-4
CNP
49
-3
CSCO
54
-3
RRC
43
-7
ADI
57
-2
URBN
58
6
CTSH
42
-3
PG
33
-2
FOX
60
-2
CMA
50
-9
PNW
49
-4
AAP
45
-2
EL
45
-7
MUR
44
-5
MAR
51
-8
GLW
45
-3
GT
46
-3
PFE
23
-6
DRI
43
-2
RF
54
-9
CF
59
-4
CNP
49
-3
CSCO
54
-3
RRC
43
-7
Financhill
Back

MiNK Therapeutics Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
51

INKT
MiNK Therapeutics

Last Price:
$23.55
Seasonality Move:
1.4%

7 Day Trial

ALL ACCESS PASS

$ 7

MiNK Therapeutics Stock Forecast

  • Over the next 52 weeks, MiNK Therapeutics has on average historically fallen by 7.4% based on the past 3 years of stock performance.
  • MiNK Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is MiNK Therapeutics Stock Undervalued?
    The current MiNK Therapeutics [INKT] share price is $28.01. The Score for INKT is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • INKT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will MiNK Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, MiNK Therapeutics has on average historically fallen by 7.4% based on the past 3 years of stock performance.

MiNK Therapeutics Stock Rating

Buy
51
MiNK Therapeutics (INKT) is a Buy

Is MiNK Therapeutics overpriced?

  • MiNK Therapeutics has fallen lower in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

MiNK Therapeutics Stock Price History

Is INKT stock going to rise?

  • The current trend is moderately bullish and INKT is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
minktherapeutics.com

52-Week Data

52-Week High:
76.00
52-Week Low:
4.56

Prediction Charts

Market Cap:
111.6M
Price in USD:
28.01
Volume:
1.5M
Beta:
0.19

Technical Analysis

SMA50:
9.54
SMA100:
8.94
SMA200:
8.25
52-Wk Change:
145.7%

Stock Predictions

  • Is MiNK Therapeutics stock public?
    Yes, MiNK Therapeutics is a publicly traded company.
  • What is the MiNK Therapeutics stock quote today?
    The MiNK Therapeutics stock price is 28.01 USD today.
  • How to buy MiNK Therapeutics stock online?
    You can buy MiNK Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-25 7.31 7.59 8.38 6.98
Jun-26 7.35 7.45 7.45 7.35
Jun-27 7.42 6.98 7.45 6.98
Jun-30 7.09 7.39 7.39 6.91
Jul-1 7.36 7.34 7.51 7.22
Jul-2 7.17 7.17 7.17 7.17
Jul-3 7.05 7.23 7.55 6.80
Jul-7 7.52 7.01 7.52 7.01
Jul-8 7.50 7.20 7.50 7.20
Jul-9 7.38 7.28 7.88 7.28
Jul-10 7.52 7.73 7.80 7.52
Jul-11 21.07 64.17 76.00 20.20
Jul-14 42.01 40.61 52.50 33.62
Jul-15 32.90 28.01 34.50 27.52

MiNK Therapeutics Earnings

MiNK Therapeutics Earnings Report: Per Share MiNK Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

MiNK Therapeutics Forecast Revenue Growth

MiNK Therapeutics Stock Analysis: Historical quarterly revenues per share for MiNK Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.35 per share, a decrease next quarter of $0.28 per share, an increase this year of $0.69 per share, and an increase next year of $0.13 per share.

* MiNK Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.